Dentsply Sirona (NASDAQ: XRAY) and Sartorius (OTCMKTS:SARTF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.
This is a summary of recent recommendations for Dentsply Sirona and Sartorius, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Dentsply Sirona presently has a consensus price target of $62.08, indicating a potential upside of 29.46%. Given Dentsply Sirona’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Dentsply Sirona is more favorable than Sartorius.
This table compares Dentsply Sirona and Sartorius’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Dentsply Sirona pays an annual dividend of $0.35 per share and has a dividend yield of 0.7%. Sartorius does not pay a dividend. Dentsply Sirona pays out 13.2% of its earnings in the form of a dividend.
Institutional & Insider Ownership
99.6% of Dentsply Sirona shares are held by institutional investors. 1.9% of Dentsply Sirona shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Dentsply Sirona and Sartorius’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Dentsply Sirona||$3.99 billion||2.73||-$1.55 billion||$2.66||18.03|
|Sartorius||$1.59 billion||2.85||$129.67 million||N/A||N/A|
Sartorius has lower revenue, but higher earnings than Dentsply Sirona.
Volatility and Risk
Dentsply Sirona has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Sartorius has a beta of -2.26, meaning that its share price is 326% less volatile than the S&P 500.
Dentsply Sirona beats Sartorius on 8 of the 15 factors compared between the two stocks.
About Dentsply Sirona
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.
Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry. It provides filtration and purification, sterile filtration, virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, integrity testing, and OEM membranes; process analysers, process control tools, microbiology products, and chemometric software; single-use bioprocess bags, containers, mixing systems, aseptic transfer systems, freeze and thaw systems, and tubing dis-/connectors; media USP and buffers DSP; bioreactors/fermentors; and FlexAct, a system that enables to custom-configure single-use solutions for entire biomanufacturing steps. The Lab Products & Services division provides laboratory instruments, such as lab balances, pipettes, and laboratory water purification systems; and consumables, including laboratory filters and pipette tips. Its products include OEM weigh cells, mass comparators and metrology, weights/weight sets, paint mixing solutions, microbiology products, and moisture analyzers; lab water systems; pipette tips and pipette calibration; bioreactors/fermentors, shakers/incubators, and centrifuges; and filtration, ultrafiltration, and membrane chromatography products, as well as virus purification kits, diagnostic membranes and arrays, and blotting membranes. The company also offers instrument, validation, training, and support information services. It serves biopharmaceutical and pharmaceutical industries, public research institutes, and chemical and food sectors. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Goettingen, Germany.
Receive News & Ratings for Dentsply Sirona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply Sirona and related companies with MarketBeat.com's FREE daily email newsletter.